| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.26 M USD | -12.69 M USD | -11.95 M USD | -19.59 M USD | -15.73 M USD | -5.68 M USD | -5.34 M USD |
| Depreciation & Amortization | 1.31 M USD | 581000 USD | 621000 USD | 669000 USD | 733000 USD | 717865 USD | 751228 USD |
| Stock-Based Compensation | 661000 USD | 762000 USD | 1.11 M USD | 2.40 M USD | 2.66 M USD | 2.17 M USD | 1.99 M USD |
| Capital Expenditures | 2.34 M USD | 568000 USD | 803000 USD | 924000 USD | 2.40 M USD | 120252 USD | 175599 USD |
| Cash Flow from Investing | -7.53 M USD | -568000 USD | -853000 USD | -924000 USD | -2.61 M USD | -120252 USD | 86223 USD |
| Cash Flow from Financing | 18.56 M USD | 17.88 M USD | 10.92 M USD | — | 24.17 M USD | 23.54 M USD | 4.47 M USD |
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — |
| Free Cash Flow | -17.60 M USD | -13.26 M USD | -12.75 M USD | -20.51 M USD | -18.13 M USD | -5.80 M USD | -5.52 M USD |
Vivos Therapeutics, Inc. is a medical technology company that concentrates on addressing sleep apnea through innovative treatment solutions. Primarily known for its proprietary systems and devices, the company offers a non-surgical approach designed to improve airway function and alleviate symptoms for patients suffering from obstructive sleep apnea (OSA), a common and often undiagnosed condition linked to various health issues. Operating at the intersection of medical devices and dental care, Vivos provides its solutions primarily to healthcare professionals, enabling them with tools and training necessary to effectively manage and treat sleep disorders. This focus on a non-invasive methodology has positioned Vivos as a notable player in the sleep disorder treatment market. Its approach not only aims to provide relief for individuals but also reduces dependency on traditional continuous positive airway pressure (CPAP) machines. Vivos Therapeutics plays a significant role in enhancing patient care within the healthcare sector by bridging the gap between dentistry and medicine, helping to raise awareness and offer alternative treatments for sleep-related breathing disorders.